EU Aims to Have Vaccines Pick Up Speed Across Continent

The video discusses Pfizer's announcement of accelerated vaccine deliveries, aiming for 250 million doses in the second quarter. It addresses the impact of Johnson & Johnson's temporary delivery halt and the EU's vaccine strategy, emphasizing safety and science-based approaches. The relationship with AstraZeneca and the focus on mRNA technology are highlighted. The video also covers vaccine distribution logistics in Europe and the development of a vaccination certificate to facilitate safe travel.

What is the significance of the European Medicines Agency in the context of vaccine approval?

What technologies are being considered for future vaccine development?

What is the expected timeline for the final proposal of the vaccination certificate?